This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
phospho-Akt1/PKBα (Ser473) Antibody, clone SK703, rabbit monoclonal
catalog :
05-736
quantity :
100 µg
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
clone name :
SK703
reactivity :
human
application :
western blot
citations: 5
| Reference |
|---|
Yamaguchi R, Harada H, Hirota K. VHL-deficient renal cancer cells gain resistance to mitochondria-activating apoptosis inducers by activating AKT through the IGF1R-PI3K pathway. Tumour Biol. 2016;37:13295-13306 pubmed
|
product information
Catalog Number :
05-736
Subcategory :
Cell Signaling
Product Name :
Anti-phospho-Akt1/PKBα (Ser473) Antibody, clone SK703, rabbit monoclonal
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Gene ID :
P31749
Host Name :
Rabbit
Antigen :
phospho-Akt1/PKBα (Ser473)
Clone :
SK703
Conjugate :
Purified
Isotype :
IgG
Product Description :
Anti-phospho-Akt1/PKBα (Ser473) Antibody, clone SK703, rabbit monoclonal
Cross Reactivity :
Human;Mouse
Immunogen :
Peptide containing a pSer that corresponds to amino acid position 473 of human Akt1/PKBa
Specificity :
phosphorylated Akt1/PKBa
Package Size :
100 µg
Uses :
Western Blotting
Storage :
Stable refrigerated at 2-8°C in undiluted aliquots for up to 1 year from date of receipt.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments
